It's a small study. Only 32 participants. But what Rookie points out is important. Lympro isn't the "screening" tool...it's the evaluation of effect tool for the drug trial. Over the course of the 30-ish weeks, there are likely to be many Lympro tests administered.

Also, the PR points to the use of Lympro in the next phase, a much larger trial.

https://www.clinicaltrials.gov/ct2/show/NCT02...amp;rank=1